Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Wide variation in caffeine discontinuation timing in premature infants.

Ji D, Smith PB, Clark RH, Zimmerman KO, Laughon M, Ku L, Greenberg RG.

J Perinatol. 2019 Nov 22. doi: 10.1038/s41372-019-0561-0. [Epub ahead of print]

PMID:
31758062
2.

Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass.

Zimmerman KO, Wu H, Laughon M, Greenberg RG, Walczak R, Schulman SR, Smith PB, Hornik CP, Cohen-Wolkowiez M, Watt KM.

Anesth Analg. 2019 Dec;129(6):1519-1528. doi: 10.1213/ANE.0000000000003700.

PMID:
31743171
3.

Bronchopulmonary dysplasia.

Thébaud B, Goss KN, Laughon M, Whitsett JA, Abman SH, Steinhorn RH, Aschner JL, Davis PG, McGrath-Morrow SA, Soll RF, Jobe AH.

Nat Rev Dis Primers. 2019 Nov 14;5(1):78. doi: 10.1038/s41572-019-0127-7. Review.

PMID:
31727986
4.

Population Pharmacokinetics of Doxycycline in Children.

Thompson EJ, Wu H, Melloni C, Balevic S, Sullivan JE, Laughon M, Clark KM, Kalra R, Mendley S, Payne EH, Erinjeri J, Gelber CE, Harper B, Cohen-Wolkowiez M, Hornik CP; Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee.

Antimicrob Agents Chemother. 2019 Sep 23. pii: AAC.01508-19. doi: 10.1128/AAC.01508-19. [Epub ahead of print]

PMID:
31548185
5.

Risk of development of treated retinopathy of prematurity in very low birth weight infants.

Gonski S, Hupp SR, Cotten CM, Clark RH, Laughon M, Watt K, Hornik CP, Kumar K, Smith PB, Greenberg RG.

J Perinatol. 2019 Nov;39(11):1562-1568. doi: 10.1038/s41372-019-0487-6. Epub 2019 Sep 6.

PMID:
31492920
6.

Population pharmacokinetics of sildenafil in extremely premature infants.

Gonzalez D, Laughon MM, Smith PB, Ge S, Ambalavanan N, Atz A, Sokol GM, Hornik CD, Stewart D, Mundakel G, Poindexter BB, Gaedigk R, Mills M, Cohen-Wolkowiez M, Martz K, Hornik CP; Best Pharmaceuticals for Children Act - Pediatric Trials Network Steering Committee.

Br J Clin Pharmacol. 2019 Dec;85(12):2824-2837. doi: 10.1111/bcp.14111. Epub 2019 Dec 15.

PMID:
31475367
7.

Correction to: Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review.

Jackson W, Taylor G, Selewski D, Smith PB, Tolleson-Rinehart S, Laughon MM.

Matern Health Neonatol Perinatol. 2019 Jul 31;5:13. doi: 10.1186/s40748-019-0108-6. eCollection 2019.

8.

Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children's hospitals.

Bamat NA, Kirpalani H, Feudtner C, Jensen EA, Laughon MM, Zhang H, Monk HM, Passarella M, Lorch SA.

J Perinatol. 2019 Sep;39(9):1291-1299. doi: 10.1038/s41372-019-0415-9. Epub 2019 Jun 21.

9.

Dosing and Safety of Off-label Use of Caffeine Citrate in Premature Infants.

Puia-Dumitrescu M, Smith PB, Zhao J, Soriano A, Payne EH, Harper B, Bendel-Stenzel E, Moya F, Chhabra R, Ku L, Laughon M, Wade KC; Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee.

J Pediatr. 2019 Aug;211:27-32.e1. doi: 10.1016/j.jpeds.2019.04.028. Epub 2019 May 14.

PMID:
31101409
10.

Creation of a Multicenter Pediatric Inpatient Data Repository Derived from Electronic Health Records.

Hornik CP, Atz AM, Bendel C, Chan F, Downes K, Grundmeier R, Fogel B, Gipson D, Laughon M, Miller M, Smith M, Livingston C, Kluchar C, Heath A, Jarrett C, McKerlie B, Patel H, Hunter C; Best Pharmaceuticals for Children Act–Pediatric Trials Network.

Appl Clin Inform. 2019 Mar;10(2):307-315. doi: 10.1055/s-0039-1688477. Epub 2019 May 8.

PMID:
31067576
11.

The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.

Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, Kirpalani H, Laughon MM, Poindexter BB, Duncan AF, Yoder BA, Eichenwald EC, DeMauro SB.

Am J Respir Crit Care Med. 2019 Sep 15;200(6):751-759. doi: 10.1164/rccm.201812-2348OC.

12.

Rifampin Pharmacokinetics and Safety in Preterm and Term Infants.

Smith PB, Cotten CM, Hudak ML, Sullivan JE, Poindexter BB, Cohen-Wolkowiez M, Boakye-Agyeman F, Lewandowski A, Anand R, Benjamin DK Jr, Laughon MM; Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00284-19. doi: 10.1128/AAC.00284-19. Print 2019 Jun.

13.

Correction: Association of chorioamnionitis and its duration with neonatal morbidity and mortality.

Venkatesh KK, Jackson W, Hughes BL, Laughon MM, Thorp JM, Stamilio DM.

J Perinatol. 2019 May;39(5):761. doi: 10.1038/s41372-019-0341-x.

PMID:
30842550
14.

Association of chorioamnionitis and its duration with neonatal morbidity and mortality.

Venkatesh KK, Jackson W, Hughes BL, Laughon MM, Thorp JM, Stamilio DM.

J Perinatol. 2019 May;39(5):673-682. doi: 10.1038/s41372-019-0322-0. Epub 2019 Feb 5. Erratum in: J Perinatol. 2019 Mar 7;:.

PMID:
30723279
15.

Pharmacokinetics of ticarcillin-clavulanate in premature infants.

Watt KM, Hornik CP, Balevic SJ, Mundakel G, Cotten CM, Harper B, Benjamin DK Jr, Anand R, Laughon M, Smith PB, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act - Pediatric Trials Network Steering Committee.

Br J Clin Pharmacol. 2019 May;85(5):1021-1027. doi: 10.1111/bcp.13882. Epub 2019 Mar 6.

PMID:
30710387
16.

Surfactant Administration in Preterm Infants: Drug Development Opportunities.

Taylor G, Jackson W, Hornik CP, Koss A, Mantena S, Homsley K, Gattis B, Kudumu-Clavell M, Clark R, Smith PB, Laughon MM.

J Pediatr. 2019 May;208:163-168. doi: 10.1016/j.jpeds.2018.11.041. Epub 2018 Dec 21.

PMID:
30580975
17.

The Association of Hydrocortisone Dosage on Mortality in Infants Born Extremely Premature.

Tolia VN, Bahr TM, Bennett MM, Martin G, Greenberg RG, Laughon MM, Clark RH.

J Pediatr. 2019 Apr;207:143-147.e3. doi: 10.1016/j.jpeds.2018.11.023. Epub 2018 Dec 21.

PMID:
30580973
18.

Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants.

Greenberg RG, Gayam S, Savage D, Tong A, Gorham D, Sholomon A, Clark RH, Benjamin DK, Laughon M, Smith PB; Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee.

J Pediatr. 2019 May;208:134-140.e2. doi: 10.1016/j.jpeds.2018.11.043. Epub 2018 Dec 20.

PMID:
30579586
19.

Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review.

Jackson W, Taylor G, Selewski D, Smith PB, Tolleson-Rinehart S, Laughon MM.

Matern Health Neonatol Perinatol. 2018 Nov 19;4:23. doi: 10.1186/s40748-018-0092-2. eCollection 2018. Review. Erratum in: Matern Health Neonatol Perinatol. 2019 Jul 31;5:13.

20.

Agreement of an echocardiogram-based diagnosis of pulmonary hypertension in infants at risk for bronchopulmonary dysplasia among masked reviewers.

McCrary AW, Barker PCA, Torok RD, Spears TG, Li JS, Hornik CP, Laughon MM.

J Perinatol. 2019 Feb;39(2):248-255. doi: 10.1038/s41372-018-0277-6. Epub 2018 Nov 21.

PMID:
30464221
21.

Trial Characteristics That Affect Parental Consent in Neonatal Drug Trials.

Hanvey IB, Aliaga S, Laughon MM, Testoni D, Smith PB, Bauserman M.

Am J Perinatol. 2019 Jun;36(7):759-764. doi: 10.1055/s-0038-1675157. Epub 2018 Oct 31.

PMID:
30380581
22.

Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.

Phelps DL, Watterberg KL, Nolen TL, Cole CA, Cotten CM, Oh W, Poindexter BB, Zaterka-Baxter KM, Das A, Lacy CB, Scorsone AM, Walsh MC, Bell EF, Kennedy KA, Schibler K, Sokol GM, Laughon MM, Lakshminrusimha S, Truog WE, Garg M, Carlo WA, Laptook AR, Van Meurs KP, Carlton DP, Graf A, DeMauro SB, Brion LP, Shankaran S, Orge FH, Olson RJ, Mintz-Hittner H, Yang MB, Haider KM, Wallace DK, Chung M, Hug D, Tsui I, Cogen MS, Donahue JP, Gaynon M, Hutchinson AK, Bremer DL, Quinn G, He YG, Lucas WR Jr, Winter TW, Kicklighter SD, Kumar K, Chess PR, Colaizy TT, Hibbs AM, Ambalavanan N, Harmon HM, McGowan EC, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

JAMA. 2018 Oct 23;320(16):1649-1658. doi: 10.1001/jama.2018.14996.

23.

Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants.

Wang LA, Smith PB, Laughon M, Goldberg RN, Ku LC, Zimmerman KO, Balevic S, Clark RH, Benjamin DK, Greenberg RG; Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee.

Early Hum Dev. 2018 Oct;125:26-30. doi: 10.1016/j.earlhumdev.2018.08.009. Epub 2018 Sep 4.

24.

Association of Atrial Septal Defects and Bronchopulmonary Dysplasia in Premature Infants.

Kumar KR, Clark DA, Kim EM, Perry JD, Wright K, Thomas SA, Thompson EJ, Greenberg RG, Smith PB, Benjamin DK Jr, Laughon MM, Clark RH, Hornik CP.

J Pediatr. 2018 Nov;202:56-62.e2. doi: 10.1016/j.jpeds.2018.07.024. Epub 2018 Aug 29.

25.

Predictors of Prolonged Breast Milk Provision to Very Low Birth Weight Infants.

Romaine A, Clark RH, Davis BR, Hendershot K, Kite V, Laughon M, Updike I, Miranda ML, Meier PP, Patel AL, Smith PB, Cotten CM, Benjamin DK Jr, Greenberg RG.

J Pediatr. 2018 Nov;202:23-30.e1. doi: 10.1016/j.jpeds.2018.07.001. Epub 2018 Aug 28.

26.

Risk factors for chronic lung disease and asthma differ among children born extremely preterm.

Jackson WM, O'Shea TM, Allred EN, Laughon MM, Gower WA, Leviton A.

Pediatr Pulmonol. 2018 Nov;53(11):1533-1540. doi: 10.1002/ppul.24148. Epub 2018 Aug 29.

27.

Dexmedetomidine Pharmacokinetics and a New Dosing Paradigm in Infants Supported With Cardiopulmonary Bypass.

Zimmerman KO, Wu H, Laughon M, Greenberg RG, Walczak R, Schulman SR, Smith PB, Hornik CP, Cohen-Wolkowiez M, Watt KM.

Anesth Analg. 2018 Aug 22. doi: 10.1213/ANE.0000000000003700. [Epub ahead of print]

PMID:
30138171
28.

Sildenafil Exposure in the Neonatal Intensive Care Unit.

Thompson EJ, Perez K, Hornik CP, Smith PB, Clark RH, Laughon M; Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee.

Am J Perinatol. 2019 Feb;36(3):262-267. doi: 10.1055/s-0038-1667378. Epub 2018 Aug 6.

PMID:
30081404
29.

External Evaluation of a Gentamicin Infant Population Pharmacokinetic Model Using Data from a National Electronic Health Record Database.

Ge S, Beechinor RJ, Hornik CP, Standing JF, Zimmerman K, Cohen-Wolkowiez M, Laughon MM, Clark R, Gonzalez D.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00669-18. doi: 10.1128/AAC.00669-18. Print 2018 Sep.

30.

Association between Furosemide Exposure and Patent Ductus Arteriosus in Hospitalized Infants of Very Low Birth Weight.

Thompson EJ, Greenberg RG, Kumar K, Laughon M, Smith PB, Clark RH, Crowell A, Shaw L, Harrison L, Scales G, Bell N, Hornik CP.

J Pediatr. 2018 Aug;199:231-236. doi: 10.1016/j.jpeds.2018.03.067. Epub 2018 May 8.

31.

Effect of Routine, Screening Head Ultrasounds on Clinical Interventions for Premature Infants.

Heling AZ, Laughon MM, Price WA.

Am J Perinatol. 2018 Aug;35(10):959-963. doi: 10.1055/s-0038-1627441. Epub 2018 Feb 16.

PMID:
29452427
32.

A pharmacokinetic model for amiodarone in infants developed from an opportunistic sampling trial and published literature data.

Dallefeld SH, Atz AM, Yogev R, Sullivan JE, Al-Uzri A, Mendley SR, Laughon M, Hornik CP, Melloni C, Harper B, Lewandowski A, Mitchell J, Wu H, Green TP, Cohen-Wolkowiez M.

J Pharmacokinet Pharmacodyn. 2018 Jun;45(3):419-430. doi: 10.1007/s10928-018-9576-y. Epub 2018 Feb 12.

33.

Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in Neonates.

Le J, Poindexter B, Sullivan JE, Laughon M, Delmore P, Blackford M, Yogev R, James LP, Melloni C, Harper B, Mitchell J, Benjamin DK Jr, Boakye-Agyeman F, Cohen-Wolkowiez M.

Ther Drug Monit. 2018 Feb;40(1):103-108. doi: 10.1097/FTD.0000000000000466.

34.

Chronic Pulmonary Insufficiency of Prematurity: Developing Optimal Endpoints for Drug Development.

Steinhorn R, Davis JM, Göpel W, Jobe A, Abman S, Laughon M, Bancalari E, Aschner J, Ballard R, Greenough A, Storari L, Thomson M, Ariagno RL, Fabbri L, Turner MA; International Neonatal Consortium.

J Pediatr. 2017 Dec;191:15-21.e1. doi: 10.1016/j.jpeds.2017.08.006. No abstract available.

PMID:
29173299
35.

Pharmacokinetics of Ceftaroline in a Preterm Infant With Methicillin-Resistant Staphylococcus Aureus Pneumonia.

Salerno SN, Bernhardt J, Laughon M, Jhaveri R, Massaro M, Gonzalez D.

J Pediatric Infect Dis Soc. 2018 Dec 3;7(4):342-345. doi: 10.1093/jpids/pix084.

36.

A Single Institution Study of Umbilical Vein Complications and Necrotizing Enterocolitis in Premature Infants.

Shah M, Phillips MR, Klein M, Marzinsky A, Rice C, Laughon M, Lee S.

Am Surg. 2017 Sep 1;83(9):e364-e366. No abstract available.

PMID:
30454354
37.

Association between oral sildenafil dosing, predicted exposure, and systemic hypotension in hospitalised infants.

Hornik CP, Onufrak NJ, Smith PB, Cohen-Wolkowiez M, Laughon MM, Clark RH, Gonzalez D.

Cardiol Young. 2018 Jan;28(1):85-92. doi: 10.1017/S1047951117001639. Epub 2017 Aug 8.

38.

50 Years Ago in The Journal of Pediatrics: A Practical Classification of Newborn Infants by Weight and Gestational Age.

Simmons MA, Laughon MM.

J Pediatr. 2017 Aug;187:33. doi: 10.1016/j.jpeds.2017.02.044. No abstract available.

PMID:
28750763
39.

Association between early echocardiography, therapy for patent ductus arteriosus, and outcomes in very low birth weight infants.

Lee JH, Greenberg RG, Quek BH, Clark RH, Laughon MM, Smith PB, Hornik CP.

Cardiol Young. 2017 Nov;27(9):1732-1739. doi: 10.1017/S1047951117001081. Epub 2017 Jun 19.

PMID:
28625190
40.

In-Hospital Outcomes Following Extracorporeal Membrane Oxygenation in a Retrospective Cohort of Infants.

Schueller M, Greenberg RG, Smith PB, Laughon MM, Clark RH, Hornik CP.

Am J Perinatol. 2017 Nov;34(13):1347-1353. doi: 10.1055/s-0037-1603593. Epub 2017 May 25. No abstract available.

41.

Population Pharmacokinetics of Dexmedetomidine in Infants.

Greenberg RG, Wu H, Laughon M, Capparelli E, Rowe S, Zimmerman KO, Smith PB, Cohen-Wolkowiez M.

J Clin Pharmacol. 2017 Sep;57(9):1174-1182. doi: 10.1002/jcph.904. Epub 2017 Apr 25.

42.

In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia.

Jackson W, Hornik CP, Messina JA, Guglielmo K, Watwe A, Delancy G, Valdez A, MacArthur T, Peter-Wohl S, Smith PB, Tolia VN, Laughon MM.

J Perinatol. 2017 Jul;37(7):853-856. doi: 10.1038/jp.2017.49. Epub 2017 Apr 6.

43.

Association between Use of Prophylactic Indomethacin and the Risk for Bronchopulmonary Dysplasia in Extremely Preterm Infants.

Jensen EA, Dysart KC, Gantz MG, Carper B, Higgins RD, Keszler M, Laughon MM, Poindexter BB, Stoll BJ, Walsh MC, Schmidt B; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

J Pediatr. 2017 Jul;186:34-40.e2. doi: 10.1016/j.jpeds.2017.02.003. Epub 2017 Feb 28.

44.

Association of in utero magnesium exposure and spontaneous intestinal perforations in extremely low birth weight infants.

Downey LC, Cotten CM, Hornik CP, Laughon MM, Tolia VN, Clark RH, Smith PB.

J Perinatol. 2017 Jun;37(6):641-644. doi: 10.1038/jp.2016.274. Epub 2017 Jan 26.

45.

Respiratory Support for Very Low Birth Weight Infants Receiving Dexamethasone.

Virkud YV, Hornik CP, Benjamin DK, Laughon MM, Clark RH, Greenberg RG, Smith PB.

J Pediatr. 2017 Apr;183:26-30.e3. doi: 10.1016/j.jpeds.2016.12.035. Epub 2017 Jan 18.

46.

Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants.

Lemyre B, Laughon M, Bose C, Davis PG.

Cochrane Database Syst Rev. 2016 Dec 15;12:CD005384. doi: 10.1002/14651858.CD005384.pub2. Review.

47.

Sedation, Analgesia, and Paralysis during Mechanical Ventilation of Premature Infants.

Zimmerman KO, Smith PB, Benjamin DK, Laughon M, Clark R, Traube C, Stürmer T, Hornik CP.

J Pediatr. 2017 Jan;180:99-104.e1. doi: 10.1016/j.jpeds.2016.07.001. Epub 2016 Aug 10.

48.

Antimicrobial Agent Dosing in Infants.

Johnson JK, Laughon MM.

Clin Ther. 2016 Sep;38(9):1948-60. doi: 10.1016/j.clinthera.2016.06.017. Epub 2016 Jul 26. Review.

PMID:
27473383
49.

Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams.

Momper JD, Capparelli EV, Wade KC, Kantak A, Dhanireddy R, Cummings JJ, Nedrelow JH, Hudak ML, Mundakel GT, Natarajan G, Gao J, Laughon M, Smith PB, Benjamin DK Jr.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5539-45. doi: 10.1128/AAC.00963-16. Print 2016 Sep.

50.

The epidemiology, prevalence and hospital outcomes of infants with gastroschisis.

Allman R, Sousa J, Walker MW, Laughon MM, Spitzer AR, Clark RH.

J Perinatol. 2016 Oct;36(10):901-5. doi: 10.1038/jp.2016.99. Epub 2016 Jul 7.

PMID:
27388940

Supplemental Content

Loading ...
Support Center